SOMAÍ Pharmaceuticals
PrivateLast Round
Early Funding
Sep 1, 2023
Total Funding Raised
$3.08M
Company Overview
SOMAÍ Pharmaceuticals is a pharmaceutical and biotechnology company that specializes in the manufacturing, research, development, and distribution of EU-GMP certified cannabinoid-containing pharmaceutical products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Quality Management
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SOMAÍ Pharmaceuticals Comparables
Compare SOMAÍ Pharmaceuticals with similar companies based on industry and business-model similarity.
SOMAÍ Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Sep 1, 2023 | ||||
| Grant | Nov 16, 2021 |
SOMAÍ Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Portugal 2020 | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 8, 2025
Grew 16% QoQ, from 56 to 65 employees.
SOMAÍ Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SOMAÍ Pharmaceuticals's valuation, stock price, and market status.